OR WAIT null SECS
June 12, 2017
The company said it expects to transaction to close on June 16, 2017.
June 08, 2017
Proceeds from the sale will be used to repay the company’s term loan debt under its Senior Secured Credit Facility.
Germany-based Grünenthal will gain rights to market and sell Zomig (zolmitriptan) outside of Japan.
The companies will collaborate on the development of dual amylin calcitonin receptor agonists for patients with Type 2 diabetes.
The company released an interim analysis from its JULIET study with CTL019.
June 06, 2017
Takeda will build a new production facility at its existing Grange Castle site in Ireland.
May 31, 2017
Amgen filed a complaint against FDA claiming the agency unlawfully denied the company pediatric exclusivity for its secondary hyperparathyroidism treatment Sensipar.
May 30, 2017
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.
The company entered two separate collaborations with Advaxis and Array Biopharma involving its PD-1 immune checkpoint inhibitor Opdivo.
The company entered a collaboration with Protagonist to develop, manufacture, and commercialize PTG-200.